Shire to Buy ViroPharma for Around $4.2 Billion

Shire to Buy ViroPharma for Around $4.2 Billion

In order to establish itself in providing treatments for rare disease, Shire Plc is going to buy ViroPharma Inc. The deal has taken place for around $4.2 billion and Shire will be paying $50 a share and that too in cash.

The recent deal is considered to be the third one for Shire. The purchase will allow Shire to have an access to Cinryze, a medicine meant for the treatment of hereditary angioedema, an inflammatory condition.

The company has said that the deal will help in raising Shire's earnings per share. In fact, as the announcement of the deal was made, Shire was able to witness a rise of 3.5% amounting to 2,894 pence.

"It's a deal that fits with our strategy of increased focus on high-growth speciality markets, particularly rare diseases", said Flemming Ornskov, CEO of Shire.

Ornskov talked about Cinryze and said that it will act a grown engine for the company. Moreover, it is an attractive drug that will prove beneficial for the company.

In addition, it has been revealed that Shire has announced that it has been planning to stop a number of programs that are taking place out of the field of rare disease.

FrenchTribune Specials

Invasion of giant moths with huge snouts hits Britain

Giant moths with huge snouts have started invading Britain in search of alcohol and tobacco.
In the late summer and early autumn, the convolvulus hawk-moth migrates from southern Europe to these shores, getting attracted by fags and booze.

With a wing-span of five inches, Hawk-moths feed off the nectar of the deep tubular flowers...

Most Popular

Children dental health vary significantly in areas, study

A healthcare charity has conducted a study to find that...

Gaining weight in midlife can increase risk of developing Alzheimer’s disease

With more number of people aging, it is predicted that...

Woman plans to start ‘no vaccines’childcare centre

A woman in Australia has said that she is planning to...


Can Greece Come out of Economic Problems: